CRBSI prevention e-learning platform – Full Text

“This study aims to assess intensive care unit (ICU) nurses’ and physicians’ knowledge regarding the Centers for Disease Control and Prevention (CDC) guidelines for preventing CVC-related infections before and after an interactive distance education delivered through the e-learning platform Teleprometheus” Foka et al (2023).

Alternative infusion system and neonatal CLABSI reduction – Full Text

“The change in perfusion system resulted in a significant decrease in the CLABSI rate (11.3 to 2.2 per 1000 catheter-days, <0.001). The period was independently associated with an 88% reduction in the risk of CLABSI after implementation (OR:0.12, 95%CI [0.03;0.39], P<0.001)" Picaud et al (2023).

Hemodialysis alternatives in CRBSI – Full Text

“We are presenting an ESRD patient with advanced vascular disease who developed metastatic CRBSI with worsening uremia who was successfully converted from intermittent hemodialysis (IHD) to peritoneal dialysis (PD)” Ghandour et al (2023).

Impact of COVID-19 on CLABSI rates – Full Text

“The COVID-19 pandemic significantly impacted CLABSI incidence/rates. Observations from the different studies highlight significant gaps in healthcare associated infections (HCAI) knowledge and practice during the pandemic, and the importance of identifying preventive measures effective in reducing CLABSI, essential to health system resilience for future pandemics” Satta et al (2023).

Pediatric CLABSI-free care

“Extended periods of CLABSI-free care in a pediatric hematology/oncology unit are achievable. A variety of factors contribute to the sustainability of being CLABSI-free. Data collection and analysis are important factors which aided in our understanding of our own CLABSI events” Thompson and Shaheen (2023).

CLABSI rate reduction project – Full Text

“Improvement projects to reduce central line-associated bloodstream infections face challenges and complexities associated with implementing interventions in real-world healthcare settings” Odada et al (2023).

CLABSI rates associated with silver containing implantable ports – Full Text

“This study aimed to investigate the efficacy of this device in reducing port infection by examining groups with and without silver-mixed devices” Suzuki et al (2023).

Central catheter hub contamination prevention

“Contamination of catheter hubs is a common cause of CLABSI. A novel, transparent line guard protects CVAD hubs from gross contamination” Doellman (2023).

Hemodialysis CLABSI rates in resource limited settings – Full Text

“In resource limited settings, where risk of complications could be higher and waiting period for transplantation longer, catheter survival determines patient survival. This study was conducted to determine infection free catheter survival rates, incidence of catheter failure and associated risk factors” Prakash et al (2023).

CLABSI following use of contaminated chlorhexidine solution – Full Text

“This result identified the culprit as being the contamination of the 4% chlorhexidine solution. The competent authorities were notified, and the disinfection method was changed to use a chlorhexidine alcohol-based solution” Gomes Cochicho et al (2023).

CLABSI rate following prophylactic antibiotic administration

“Despite the frequency of VAD procedures in children, the effectiveness of prophylactic antibiotics for reducing infectious complications is unknown” Papastefan et al (2023).

Implantable port yeast infection case study

” We report a case of bloodstream infection related to an implantable venous access port. W. myanmarensis was isolated from patient’s blood after chemotherapy, which was meant to control and heal T-cell lymphoblastic lymphoma” Aminasnafi et al (2023).

CRBSI risk in patients with intestinal failure

“CRBSIs can still develop despite undergoing prophylactic management. Risk factors for CRBSI include the residual intestinal length, nutritional status, and susceptibility to certain microorganisms” Sakurai et al (2023).

CLABSI two-year surveillance outcomes – Full Text

“The healthcare-associated risk factors such as longer length of ICU stay and prolonged duration of central venous catheterization are the risk factors for developing central line-associated bloodstream infections (BSI)” Maqbool et al (2023).

CRBSI rates in Northern Italy

“Tunneled central venous catheter (tCVCs) is a vascular access frequently employed in hemodialysis patients. Catheter-related bloodstream infections (CRBSI) are potentially life-threatening complications” Mandolfo et al (2023).

Educational intervention and CLABSI prevention – Full Text

“To assess the effect of an educational intervention based on clinical simulation on nursing professionals’ compliance with practices to prevent peripherally inserted central venous catheter-associated primary bloodstream infections in a Neonatal Intensive Care Unit” Oliveira et al (2023).

CLABSI prevention practices

“CLABSI cases can provide insight into adherence to guideline-recommended prevention practices and identify areas for improvement at individual institutions” Harrington et al (2023).

Candida CLABSI rates during COVID-19 pandemic

“During the COVID-19 pandemic, our facility experienced a significant increase in Candida CLABSI and a significant correlation of Candida CLABSIs with acute care COVID-19 hospitalizations” Ford et al (2023).

Hemodialysis catheter CLABSI rates – Full Text

“The purpose of this study was to the determine the central venous catheter-related infection rate at a dialysis center in the Brazilian state of Amazonas and to identify risk factors and the microbiological profile of the infections” Matos et al (2023).

CLABSI incidence in Northern India – Full Text

“The prevention of CLABSI requires knowledge of the infection rates and of the sources, the pathogens involved as well as their antimicrobial profile” Maqbool and Sharma (2023).

Managing CRBSI during home parenteral nutrition

“In this international survey of HPN expert centers, we observed a significant consensus regarding the initial management of CRBSI and the use of secondary preventive CVC locks, while areas of variation exist” Joly et al (2023).

Haemodialysis infection prevention guidance compliance

“Despite good overall compliance, this survey highlights some shortcomings in complying with infection prevention guidelines, which could be associated with either higher vascular access infection risk or with increased blood-borne virus transmission” Habihirwe et al (2023).

Paediatric CLABSI risk factors – Full Text

“The objective of our study is to evaluate the association of factors and the etiology causing CLABSI” Sellamuthu et al (2023).

Hemodialysis tunneled catheter CRBSI in older persons

“Clinical characteristics and outcomes of CRBSI were comparable among old and young hemodialysis patients” Bnaya et al (2023).

Hemodialysis CLABSI systematic review

“The rate of bacteremia in the studies ranged from 0.2 to 5.47 events per 1000 catheter days after the application of nursing care” Hernán et al (2023).

Role of biofilm in CVC candidemia – Full Text

“Hence, alternative strategies have been developed to manage Candida biofilm. Current options for prevention or therapy in combination with systemic antifungal medications include lock therapy, catheter coating, natural peptide products and photodynamic inactivation” Wijaya et al (2023).

Virtual reality neonatal CLABSI education – Full Text

“The VR_AICENICU program has implications for the education needs of nurses working in NICUs and enhances their knowledge and performance of infection control” Ryu and Yu (2023).

CLABSI prevention in critically ill patients – Full Text

“These findings may provide other health systems with additional strategies to prevent CLABSI and provide consistent, evidence-based supportive care to critically ill patients” Harris et al (2023).

Targeted CLABSI prevention

“The overall CLABSI rate (infections per 1000 line days) at the 9 facilities in the 6 months prior to intervention was 1.42, and the postassessment rate in the 6 months following intervention was 0.44” Bartles et al (2023).

CLABSI rates following reuse of peripheral ECMO cannulation sites

“This study investigates the risk of infectious complication associated with the reuse of peripheral ECMO cannulation sites for subsequent central venous access” Chan et al (2023).